What questions do you have about what's next in Ukraine?
Social Sharing
What questions do you have about what's next in Ukraine?
After an explosive press conference, a mineral deal between the United States and Ukraine is off the table for now. What does this mean for a war that has been going on for 3 years now? What's next for Ukraine? And how does a shifting geopolitical landscape affect countries like Canada? We've booked Paul Goode. He's an Associate Professor and McMillan Chair of Russian Studies at the Institute of European, Russian and Eurasian Studies at Carleton University. Ann Fitz-Gerald is the Director of the Balsillie School of International Affairs and a Professor in Wilfrid Laurier University's Political Science Department. They'll both take your questions!
What questions do you have about an increase in early onset cancers?
More adults under the age of 50 are being diagnosed with cancer -- and doctors aren't sure why exactly. The trend is apparent in specific types of cancers -- such as colorectal and breast cancer. And doctors say that an increase in obesity and sedentary lifestyles could be to blame. What questions do you have about early-onset cancer? Tim Caulfield is a Law professor and research director of the Health Law Institute at the University of Alberta, and an expert in medical misinformation. He'll be among the guests who will be on the show.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Ottawa Citizen
2 days ago
- Ottawa Citizen
ALS took his father. Now this Carleton researcher is fighting back
It was a conversation Daniel Knight will not forget. The Carleton University researcher's father had recently been diagnosed with ALS. What Knight said seems prescient now. Article content 'I just told him that one day I would be part of the solution. He said thank you. We really didn't need to say anything else.' Article content Article content Knight's sixty-year-old father, John, a 'self-proclaimed nerd' who loved everything to do with space and aviation, was diagnosed with an aggressive form of the neurological condition amyotrophic lateral sclerosis (ALS) in 2019. He died just six months later, one of three siblings in his family taken by the devastating disease. Article content Article content At the time, Knight was a 19-year-old undergrad studying chemistry at Carleton University with no concrete plans for his future. He admits he didn't really know how he could be part of a solution to ALS, but felt strongly that he had to do something to help people with the disease that had been so prevalent in his father's family. Article content Article content 'To be honest, I didn't have a clue. I just knew I couldn't sit back. The only thing on my mind was volunteering or fundraising.' Article content ALS is a neurological condition that affects motor neurons — the wires that connect the brain to the muscles. Approximately 4,000 Canadians are affected. The majority will survive between two and five years after being diagnosed. Some, like John Knight, survive for less than a year. Others live beyond five years. Article content His father's illness and the family history of the disease has driven Knight to be one of the researchers working to make a difference for ALS patients. Article content Article content Article content Today, the 25 year old from Navan is working on his PhD in chemistry at Carleton and leading groundbreaking scientific research that is part of a wave of work raising hopes of potential new treatments for ALS. Article content Article content The support of one of his professors during his father's illness and her subsequent mentorship has helped shape Knight's research. Article content Knight was in his second year studying chemistry when his father became ill. He had to navigate his studies while trying to spend time with his father. Article content Among his courses at the time was one taught by Maria DeRosa, a chemistry professor and researcher who is now Dean of Science at Carleton. Her overwhelming support and sympathy, along with her approach to teaching and to students, made Knight think she was someone he would like to work with to continue his studies. Article content He became interested in her work, which includes the use of aptamers. The synthetically produced single-stranded DNA molecules can selectively bind to any target they are designed to bind to, including specific proteins. That makes them an important research tool. Aptamers have a long list of potential applications — including in healthcare.
Japan Forward
3 days ago
- Japan Forward
Rehabilitation in Ukraine Gets a Boost from Japanese Robotics
このページを 日本語 で読む As the outcome of the war between Ukraine and Russia remains uncertain, a new initiative has begun to support wounded Ukrainians using Japanese medical technology. The effort involves helping individuals with brain injuries from bombings or gunfire relearn how to walk using a lightweight robotic walking aid. Professor Emeritus Rui Yuge of Hiroshima University and his team developed the device. In Ukraine, many doctors are among those conscripted. Strained by staff shortages, this "Hinomaru medical technology" is making a vital contribution to the medical system. At one of Ukraine's largest rehabilitation centers in Lviv, a 31-year-old man slowly made his way down a corridor, gripping a cane in his right hand. He had been shot at close range by a Russian soldier and suffered a severe trauma to the right side of his head. The injury left the left side of his body paralyzed and confined him to a wheelchair. But on this day, something remarkable happened. Within ten minutes, his pace quickened, and he was soon walking without the cane. Strapped to his left ankle was a lightweight robotic device called a RE-Gait. Jointly developed by Dr Rui Yuge and a team at Waseda University, the RE-Gait walking assist robot uses a motor to support ankle movement, helping users regain independent mobility. Made from carbon fiber, it weighs just one kilogram. "We designed it to be both effective and as light as possible," Yuge said. The RE-Gait device can be customized via tablet to match each patient's unique gait. This makes it suitable for a wide range of conditions, including stroke, traumatic brain injury, Parkinson's disease, and knee osteoarthritis. It supports natural foot movement, such as lifting the toes and landing on the heel, while helping the brain relearn proper walking mechanics. This reduces abnormal patterns and promotes functional recovery. Dr Rui Yuge, Professor Emeritus at Hiroshima University (right), stands with Ukrainian physician Liubov Koloshynska (©Sankei by Nobuhiko Yamaguchi). Since its domestic launch in 2016, Japanese medical institutions have used RE-Gait in more than 1,000 cases across. "When patients use RE-Gait for rehabilitation several times a week, they gradually develop a proper walking form," says Dr Yuge. His decision to support war-torn Ukraine, under Russian invasion since February 2022, was partly shaped by his personal experience. Around 25 years ago, Yuge studied abroad in Canada. It was an experience that deepened his appreciation for international cooperation and cross-border medical support. "I received a scholarship to study abroad, and it was Ukrainians at the university who supported me during that time," Dr Yuge recalled. "When I saw what was happening in Ukraine after the invasion, I felt compelled to give back using the technology I've developed." Together with a Georgian neurosurgeon and an international NGO, he began exploring ways to provide direct support. In April 2025, he donated two RE-Gait units to the rehabilitation center in Lviv. "We've already received feedback that many patients are using the device," he said. "It's easy to use, and it delivers results quickly." Before the donation, Ukrainian physician Liubov Koloshynska traveled to Japan to receive training on the device. She explained that patients from other destroyed medical facilities had been relocated to their center, leading to a severe staffing shortage. Technologies like RE-Gait, she added, have been an enormous help in managing the increased demand. With conflicts affecting people worldwide, Dr Yuge hopes this initiative can go further. "I want to expand this support beyond Ukraine, working in partnership with governments and other organizations," he said. Author: Nobuhiko Yamaguchi, The Sankei Shimbun このページを 日本語 で読む
Toronto Star
27-05-2025
- Toronto Star
AP PHOTOS: More than 200 Ukrainian POWs have died in Russian prisons
KYIV, Ukraine (AP) — More than 200 Ukrainian POWs have died while imprisoned since Russia's full-scale invasion three years ago. Abuse inside Russian prisons was likely a contributing factor in many of these deaths, according to officials from human rights groups, the U.N., the Ukrainian government and a Ukrainian medical examiner who has performed dozens of POW autopsies. The officials say the prison death toll adds to evidence that Russia is systematically brutalizing captured soldiers. They say forensic discrepancies, and the repatriation of bodies that are mutilated and decomposed, point to an effort to cover up alleged torture, starvation and poor health care at dozens of prisons and detention centers across Russia and occupied Ukraine.
